In managing hypertension, patient participation and understanding of the nature and significance of treatment are decisive.
We analysed the communication between patient and physician with respect to antihypertensive medication at a follow-up appointment, and assessed patients'knowledge of their medication.
The empirical data consist of audio-recordings from 51 hypertensive patients'follow-up appointment with their physicians.
Thirty-three of these patients were interviewed in depth immediately after the appointment.
The study was performed in primary health care centres and at a specialist clinic for hypertension.
When discussing medications, patients mainly talked about experiences of being on medication, whereas physicians generally focused on the pharmacological effect and dosage of the drug.
Physicians routinely asked about compliance with drug regimen, but seldom in any depth.
Little effort was invested into discussing the effect and goal of therapy.
The main finding was that patients had a very fragmentary understanding of the functional nature of their antihypertensive medication.
This is unsatisfactory both from the point of view of treatment efficacy and also when considering the legal requirements of involving the patient in the decision making.
The follow-up appointments studied gave few possibilities for the patient to learn about their antihypertensive medication.
Mots-clés Pascal : Hypertension artérielle, Antihypertenseur, Education santé, Malade, Communication, Chimiothérapie, Traitement, Observance thérapeutique, Homme, Appareil circulatoire pathologie
Mots-clés Pascal anglais : Hypertension, Antihypertensive agent, Health education, Patient, Communication, Chemotherapy, Treatment, Treatment compliance, Human, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0307127
Code Inist : 002B02F05. Création : 27/11/1998.